CareDx, Inc
CDNA
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cā¦ read more
Healthcare
Diagnostics & Research
11 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$15.62
Price+4.06%
$0.61
1Y
Price
Market Cap
$803.408m
Small
Price/Earnings 3y Avg5y Avg
11.7x
Premium
Premium
Financials Overview
Key metrics over the past few years-4.6%
EBITDA Margin-9.9%
Net Profit Margin+11.4%
Free Cash Flow MarginRevenue
$340.826m
+2.1%
1y CAGR+2.8%
3y CAGR+4.2%
5y CAGREarnings
$51.681m
-1.6%
1y CAGR-7.5%
3y CAGR-43.1%
5y CAGREPS
$1.02
+9.7%
1y CAGR-3.3%
3y CAGR-38.5%
5y CAGRBook Value
$327.370m
$444.257m
Assets$116.887m
Liabilities$29.122m
DebtDebt to Assets
6.6%
-1x
Debt to EBITDAFree Cash Flow
$17.847m
-43.5%
1y CAGR+71.7%
3y CAGR+47.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company